As of Mar 27
| +0.06 / +0.43%|
The 7 analysts offering 12-month price forecasts for Exone Co have a median target of 17.00, with a high estimate of 27.00 and a low estimate of 14.50. The median estimate represents a +21.78% increase from the last price of 13.96.
The current consensus among 10 polled investment analysts is to Hold stock in Exone Co. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.